Antithrombin III tours gene: identification of a point mutation leading to an arginine----cysteine replacement in a silent deficiency.

Nucleic acids research ·Vol. 14 ·No. 5 ·1986-03-11 ·Pages 2408

Duchange N, Chassé JF, Cohen GN, Zakin MM

Abstract

暂无摘要

MeSH Terms

Amino Acid Sequence Antithrombin III/genetics Antithrombin III Deficiency Humans Mutation

Chemicals

antithrombin III Tours Antithrombin III

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Duchange N

Chassé J F

Cohen G N

Zakin M M

References (5)

5 references, click to expand

Isolation of a cDNA clone for human antithrombin III.
J Biol Chem. 1983 Jul 10;258(13):8389-94 PMID: 6305982
Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis.
Thromb Res. 1983 Jul 15;31(2):305-17 PMID: 6636045
Modified oligonucleotides as alternatives to the synthesis of mixed probes for the screening of cDNA libraries.
Proc Natl Acad Sci U S A. 1985 Nov;82(22):7510-4 PMID: 3865174
An abnormal plasma antithrombin with no apparent affinity for heparin.
Thromb Res. 1984 May 15;34(4):297-302 PMID: 6204398
Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.
Proc Natl Acad Sci U S A. 1984 Jan;81(2):289-93 PMID: 6582486

Article Info

Journal

Nucleic acids research

Abbr.

Nucleic Acids Res

ISSN

0305-1048

DOI

Published

1986-03-11

Pages

2408

Language

English

Region

England

NLM ID

0411011

PMCID

PMC339667

Subset

External Links

Analysis Services